Tumor promoting effect of PDLIM2 downregulation involves mitochondrial ROS, oncometabolite accumulations and HIF-1α activation

Jingxing Yang, Tsung‐Hsien Chuang|Journal of Experimental & Clinical Cancer Research|2024

Cited by 15